Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
As a disease-modifying agent,
glucosamine has been shown to
provide as much as a 54% reduction in
the 3-year progression of joint space
narrowing, an indicator of OA
progression.
As a symptom-modifying agent,
glucosamine minimizes long-term joint
pain and stiffness and improves joint
function.